首页> 外国专利> MEDICAL PROGNOSIS AND PREDICTION OF TREATMENT RESPONSE USING MULTIPLE CELLULAR SIGNALLING PATHWAY ACTIVITIES.

MEDICAL PROGNOSIS AND PREDICTION OF TREATMENT RESPONSE USING MULTIPLE CELLULAR SIGNALLING PATHWAY ACTIVITIES.

机译:利用多种细胞信号通路活动进行医学预测和治疗反应预测。

摘要

The present application relates to a method for determining a risk score that indicates a risk that a clinical event will occur within a certain period of time. The risk score is based at least in part on a combination of inferred activities of two or more cellular signaling pathways in a tissue and/or cells and/or a body fluid of a subject. The cellular signaling pathways comprise a Wnt pathway, an ER pathway, an HH pathway, and/or an AR pathway. The risk score is defined such that the indicated risk that the clinical event will occur within the certain period of time decreases with an increasing P ER and increases with an increasing max(P Wnt, P HH ), wherein P ER , P wnt , and P HH i/denote the inferred activity of the ER pathway, the Wnt pathway, and the HH pathway, respectively.
机译:本申请涉及一种用于确定风险分数的方法,该风险分数指示临床事件将在一定时间段内发生的风险。风险评分至少部分基于受试者的组织和/或细胞和/或体液中两个或多个细胞信号通路的推断活性的组合。细胞信号传导途径包括Wnt途径,ER途径,HH途径和/或AR途径。定义风险评分,以使临床事件在一定时间内发生的指示风险随P ER的增加而降低,而随max(P Wnt,P HH)的增加而增加,其中P ER,P wnt和P HH分别表示ER途径,Wnt途径和HH途径的推断活性。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号